雷公藤萜类化合物的抗肿瘤作用机制及联合治疗研究进展

    Research Progress on Anti-tumor Mechanism and Combined Therapy of Terpenoids from Tripterygium Wilfordii

    • 摘要: 恶性肿瘤是严重威胁人类健康的重大慢性疾病,手术切除并联合药物辅助治疗是抗肿瘤治疗的主要手段,但如今的抗肿瘤药物多存在耐药性和不良反应。随着近年来肿瘤发病率的不断增加,使用安全、有效的中医药治疗肿瘤成为热点。雷公藤是中国的一种传统中药,已被证实对多种恶性肿瘤均具有显著治疗效果,其有效成分中萜类化合物雷公藤甲素和雷公藤红素被认为是传统中医药治疗肿瘤的代表药物。本文全面阐述了雷公藤萜类化合物发挥抗肿瘤的作用机制,并对其联合治疗进行分析和拓展,以期为雷公藤萜类化合物的深入研究和临床应用提供理论依据和研究思路。

       

      Abstract: Malignant tumors are a major chronic disease that poses a serious threat to human health. Surgical resection combined with drug assisted therapy is the main method of anti-tumor treatment, but nowadays, many anti-tumor drugs have drug resistance and adverse reactions. With the increasing incidence rate of tumors in recent years, the treatment of tumors with safe and effective traditional Chinese medicine has become a hot spot. Tripterygium wilfordii is a traditional Chinese medicine in China, which has been proven to have significant therapeutic effects on various malignant tumors. Among the active ingredients, the terpenoid compounds triptolide and celastrol are considered representative drugs for traditional Chinese medicine in treating tumors. This article comprehensively elaborated on the anti-tumor mechanism of terpenoids from Tripterygium wilfordii, and analyzed and expanded their combined therapy, in order to provide theoretical basis and research ideas for the in-depth research and clinical application of terpenoids from Tripterygium wilfordii.

       

    /

    返回文章
    返回